$ELOX
Eloxx Pharmaceuticals, Inc.

2019 Q1 Form 10-Q Financial Statement

#000156459019017648 Filed on May 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.960M $3.390M
YoY Change 75.81% 1440.91%
% of Gross Profit
Research & Development $6.019M $4.394M
YoY Change 36.98% 86.58%
% of Gross Profit
Depreciation & Amortization $30.00K $21.00K
YoY Change 42.86% 250.0%
% of Gross Profit
Operating Expenses $11.98M $8.548M
YoY Change 40.11% 224.77%
Operating Profit -$11.98M -$8.548M
YoY Change 40.11% 224.77%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $60.00K -$43.00K
YoY Change -239.53% -96.97%
Pretax Income -$11.92M -$8.590M
YoY Change 38.77% 315.77%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.92M -$8.591M
YoY Change 38.71% 220.8%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$331.9K -$312.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.50M $18.29M
YoY Change 192.53% 7520.83%
Cash & Equivalents $44.58M $18.29M
Short-Term Investments $8.928M
Other Short-Term Assets $1.960M $560.0K
YoY Change 250.0% 1766.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $55.46M $18.84M
YoY Change 194.36% 6820.25%
LONG-TERM ASSETS
Property, Plant & Equipment $1.340M $314.0K
YoY Change 326.75% 422.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $94.00K
YoY Change
Total Long-Term Assets $1.431M $314.0K
YoY Change 355.73% -94.36%
TOTAL ASSETS
Total Short-Term Assets $55.46M $18.84M
Total Long-Term Assets $1.431M $314.0K
Total Assets $56.89M $19.16M
YoY Change 197.0% 227.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.240M $2.173M
YoY Change 3.08% 1890.91%
Accrued Expenses $4.597M $3.478M
YoY Change 32.17% 2101.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $984.0K
YoY Change
Total Short-Term Liabilities $8.420M $5.651M
YoY Change 49.0% 434.39%
LONG-TERM LIABILITIES
Long-Term Debt $13.41M $0.00
YoY Change
Other Long-Term Liabilities $630.0K
YoY Change
Total Long-Term Liabilities $13.41M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.420M $5.651M
Total Long-Term Liabilities $13.41M $0.00
Total Liabilities $22.46M $5.650M
YoY Change 297.52% 73.45%
SHAREHOLDERS EQUITY
Retained Earnings -$98.06M -$47.55M
YoY Change 106.22% -60.19%
Common Stock $133.4M $61.06M
YoY Change 118.46% 22580.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.43M $13.51M
YoY Change
Total Liabilities & Shareholders Equity $56.89M $19.16M
YoY Change 197.0% 227.87%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$11.92M -$8.591M
YoY Change 38.71% 220.8%
Depreciation, Depletion And Amortization $30.00K $21.00K
YoY Change 42.86% 250.0%
Cash From Operating Activities -$9.190M -$5.697M
YoY Change 61.31% 108.6%
INVESTING ACTIVITIES
Capital Expenditures $16.00K $57.00K
YoY Change -71.93% -22.97%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$8.942M -$57.00K
YoY Change 15587.72% -40.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $455.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.180M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -9.190M -5.697M
Cash From Investing Activities -8.942M -57.00K
Cash From Financing Activities 5.180M 0.000
Net Change In Cash -8.942M -5.754M
YoY Change 55.4% 1467.85%
FREE CASH FLOW
Cash From Operating Activities -$9.190M -$5.697M
Capital Expenditures $16.00K $57.00K
Free Cash Flow -$9.206M -$5.754M
YoY Change 59.99% 105.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
8928000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
45000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1690000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
50341000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1106000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
94000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
129000
CY2019Q1 us-gaap Assets
Assets
56891000
CY2018Q4 us-gaap Assets
Assets
50718000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2240000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
747000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4597000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6938000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
984000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
481000
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
122000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7807000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13409000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
360000
CY2019Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1250000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
133383000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
129825000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98062000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86145000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
34433000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
42911000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4394000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3393000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11977000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56891000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50718000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36047498
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35951537
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35945608
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35860114
CY2019Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
101890
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
91423
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6019000
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11916000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8591000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-11917000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-8591000
CY2019Q1 elox Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
114000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1493000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1358000
CY2019Q1 elox Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-114000
CY2019Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
3000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
8923000
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
276000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1104000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
455000
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
25000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5000
CY2019Q1 elox Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations In Reconciliation
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsInReconciliation
44621000
CY2018Q1 elox Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations In Reconciliation
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsInReconciliation
18396000
CY2019Q1 elox Noncash Acquisition Of Treasury Shares
NoncashAcquisitionOfTreasuryShares
121000
CY2019Q1 elox Fair Value Of Warrants Issued In Connection With Long Term Debt
FairValueOfWarrantsIssuedInConnectionWithLongTermDebt
421000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
93000
CY2019Q1 elox Non Cash Final Payment On Debt Financing Obligation
NonCashFinalPaymentOnDebtFinancingObligation
900000
CY2019Q1 elox Number Of Rare And Ultra Rare Disease Due To Premature Stoppage Of Codons
NumberOfRareAndUltraRareDiseaseDueToPrematureStoppageOfCodons
1800
CY2019Q1 elox Cash And Cash Equivalent And Available For Sale Debt Securities
CashAndCashEquivalentAndAvailableForSaleDebtSecurities
53504000
CY2019Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2019Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
44576000
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
8927000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
8928000
CY2019Q1 elox Cash And Cash Equivalent And Available For Sale Debt Securities Amortized Cost
CashAndCashEquivalentAndAvailableForSaleDebtSecuritiesAmortizedCost
53503000
CY2019Q1 elox Cash And Cash Equivalent And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2019Q1 us-gaap Prepaid Insurance
PrepaidInsurance
325000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
251000
CY2019Q1 elox Contract Receivable Current
ContractReceivableCurrent
26000
CY2018Q4 elox Contract Receivable Current
ContractReceivableCurrent
20000
CY2019Q1 elox Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
1215000
CY2018Q4 elox Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
864000
CY2019Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
345000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
555000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
468000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
452000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
237000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
204000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1060000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2562000
CY2019Q1 elox Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
2688000
CY2018Q4 elox Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
3086000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
583000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
985000
CY2019Q1 elox Accrued Interest On Debt
AccruedInterestOnDebt
103000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
163000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
305000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
CY2019Q1 elox Operating Lease Estimated Incremental Borrowings Rate
OperatingLeaseEstimatedIncrementalBorrowingsRate
0.08
CY2019Q1 elox Operating Lease Present Value At Inception
OperatingLeasePresentValueAtInception
1500000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
413000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
493000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
310000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1216000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
110000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1106000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
541000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
490000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
310000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1341000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
917000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5623000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5659000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5252000
CY2019Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
420000
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
17871000
CY2019Q1 elox Long Term Debt Interest Expense
LongTermDebtInterestExpense
2871000
CY2019Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1507000
CY2019Q1 elox Long Term Debt Net Of Current Portion And Discount Excluding Final Fee
LongTermDebtNetOfCurrentPortionAndDiscountExcludingFinalFee
12509000
CY2019Q1 elox Long Term Debt Maturities Final Fee Due
LongTermDebtMaturitiesFinalFeeDue
900000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000
CY2019Q1 elox Restricted Stock Vested During Period Value
RestrictedStockVestedDuringPeriodValue
-121000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2910232
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
347241
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
388075
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.77
CY2019Q1 elox Class Of Warrant Or Right Granted In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedInPeriodWeightedAverageExercisePrice
11.02
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.53
CY2018 elox Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P3Y11M1D
CY2019Q1 elox Class Of Warrant Or Right Granted Expiration Period
ClassOfWarrantOrRightGrantedExpirationPeriod
P10Y
CY2019Q1 elox Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P4Y3M29D
CY2018Q2 elox Number Of Equity Based Compensation Plans
NumberOfEquityBasedCompensationPlans
2
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3261719
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
804100
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
118996
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3921823
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1084567
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.09
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.71
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.00
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.37
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.07
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.49
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M21D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M1D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M1D
CY2019Q1 elox Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
40834
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11650373
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10417568
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6507695
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
421000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2658000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21360000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
735000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
13504000
CY2019Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
40834
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4928446

Files In Submission

Name View Source Status
0001564590-19-017648-index-headers.html Edgar Link pending
0001564590-19-017648-index.html Edgar Link pending
0001564590-19-017648.txt Edgar Link pending
0001564590-19-017648-xbrl.zip Edgar Link pending
elox-10q_20190331.htm Edgar Link pending
elox-20190331.xml Edgar Link completed
elox-20190331.xsd Edgar Link pending
elox-20190331_cal.xml Edgar Link unprocessable
elox-20190331_def.xml Edgar Link unprocessable
elox-20190331_lab.xml Edgar Link unprocessable
elox-20190331_pre.xml Edgar Link unprocessable
elox-ex311_8.htm Edgar Link pending
elox-ex312_9.htm Edgar Link pending
elox-ex321_7.htm Edgar Link pending
elox-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending